3Saran R, Dykstra D M, Wolfe R A, et al. Association between vascular access failure and the use of specific drugs: the dialysis outcomes and practice patterns study (DOPPS)[J]. Am J Kidney Dis, 2002,40(6) : 1255-1263.
4Da Silva A F, Escofet X, Rutheford P A. Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts [DB/OL] [J]. Cochrane Database Syst Rev, 2003, (2): CD002786.
5Wong V, Ward R, Taylor J, et al. Facfors associated with early failure of arteriovenous fistulae for he Nodialysis access [J]. Eur J Endovascul Sur, 1996,12(2) :207-213.
6Roberts DE,McNicol A,Bose R.Mechanism of collagen activation in human platelets[J].J Biol Chem,2004,279(19):19421～19430.
7Ando Y.Biochemistry of platelet membrane glycoproteins[J].Nippon Rinsho,2003,61(4):547～55 1.
8Mckenzie ME,Malinin AI,Bell CR,et al.Aspirin inhibits surface glycoprotein Ⅱ b/Ⅲa,P-selectin,CD63,and CD107a receptor expression on human platelets[J].Blood Coagul Fibrinolysis,2003,14(3):249～253.
